<DOC>
	<DOCNO>NCT00331331</DOCNO>
	<brief_summary>This study examine proteins people uveitis , inflammation eye . Evaluating vitreous , colorless transparent substance fill eyeball back lens , possible use new microtechnology . There opportunity evaluate kind proteins present severe , noninfectious sight-threatening uveitis . Patients age 18 older enrol Multicenter Uveitis Steroid Treatment ( MUST ) study NIH may eligible study . Up 200 patient eventually may enrol . Researchers study vitreous remove patient ' eye operation insert steroid implant . The steroid implant use instead immunosuppressive therapy , way reduce action immune system . Patients undergo procedure involve small hole make eye implant place . Normally small amount vitreous come procedure , study , vitreous specimen take test inflammatory product . At time , small sample blood , 1-1/2 tablespoon , collect researcher compare inflammatory product may blood vitreous . If patient need implant place study , would ask permission collection vitreous blood sample , previously . Samples collect use diagnose patient ' condition change treatment do . All sample label special code number identify information patient . This study involve examination schedule visit patient .</brief_summary>
	<brief_title>The Vitreous Proteome Inflammatory Mediators Ocular Inflammatory Disease</brief_title>
	<detailed_description>Newer therapy treat many ocular disorder include uveitis consider studied . We clear picture lymphokines/chemokines present vitreous anterior chamber fluid patient active intraocular inflammatory disease well disorder propose inflammatory component age relate macular degeneration ( AMD ) diabetes . Further , study yet perform evaluate proteome vitreous anterior chamber fluid uveitic , AMD diabetic state . This natural history study specimens take indicated surgery patient uveitis study . Specimens anterior chamber fluid vitreous evaluate 32 cytokine proteome use system permit evaluation small amount material . A serum sample take time compare lymphokine profile find vitreous . Previously , patient participate MUST ( Multicenter Uveitis Steroid Treatment ) study , randomize study evaluate ocular steroid implant versus standard immunosuppressive therapy treatment intermediate posterior uveitis , enrol . However , MUST study complete ; currently accept participant NEI intramural NIH study permission obtain patient allow evaluation do .</detailed_description>
	<mesh_term>Uveitis</mesh_term>
	<mesh_term>Vasculitis</mesh_term>
	<criteria>INCLUSION CRITERIA : Participants must participate study permit evaluation specimen . EXCLUSION CRITERIA : Eligible participant wish donate vitreous specimen anterior chamber fluid , appropriate , blood sample undergo blood draw purpose research study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 26, 2016</verification_date>
	<keyword>Uveitis</keyword>
	<keyword>Intermediate Uveitis</keyword>
	<keyword>Pars Planitis</keyword>
	<keyword>Macular Edema</keyword>
	<keyword>Vasculitis</keyword>
	<keyword>Ocular Inflammatory Disease</keyword>
</DOC>